|
1
|
Chou AJ, Merola PR, Wexler LH, et al:
Treatment of osteosarcoma at first recurrence after contemporary
therapy: the Memorial Sloan-Kettering Cancer Center experience.
Cancer. 104:2214–2221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakase M, Inui M, Okumura K, Kamei T,
Nakamura S and Tagawa T: p53 gene therapy of human osteosarcoma
using a transferrin-modified cationic liposome. Mol Cancer Ther.
4:625–631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: a review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Z and Klionsky DJ: Eaten alive: a
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klionsky DJ: The molecular machinery of
autophagy: unanswered questions. J Cell Sci. 118:7–18. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levine B and Klionsky DJ: Development by
self-digestion: molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizushima N: The pleiotropic role of
autophagy: from protein metabolism to bactericide. Cell Death
Differ. 12(Suppl 2): 1535–1541. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rubinsztein DC, Gestwicki JE, Murphy LO
and Klionsky DJ: Potential therapeutic applications of autophagy.
Nat Rev Drug Discov. 6:304–312. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang WP and Klionsky DJ: Autophagy in
yeast: a review of the molecular machinery. Cell Struct Funct.
27:409–420. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo S and Rubinsztein DC: Apoptosis blocks
Beclin 1-dependent autophagosome synthesis: an effect rescued by
Bcl-xL. Cell Death Differ. 17:268–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Del Bello B, Toscano M, Moretti D and
Maellaro E: Cisplatin-induced apoptosis inhibits autophagy, which
acts as a pro-survival mechanism in human melanoma cells. PLoS One.
8:e572362013.PubMed/NCBI
|
|
12
|
Hippert MM, O’Toole PS and Thorburn A:
Autophagy in cancer: good, bad, or both? Cancer Res. 66:9349–9351.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thorburn A: Apoptosis and autophagy:
regulatory connections between two supposedly different processes.
Apoptosis. 13:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Djavaheri-Mergny M, Maiuri MC and Kroemer
G: Cross talk between apoptosis and autophagy by caspase-mediated
cleavage of Beclin 1. Oncogene. 29:1717–1719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou W, Han J, Lu C, Goldstein LA and
Rabinowich H: Autophagic degradation of active caspase-8: a
crosstalk mechanism between autophagy and apoptosis. Autophagy.
6:891–900. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lowe SW, Ruley HE, Jacks T and Housman DE:
p53-dependent apoptosis modulates the cytotoxicity of anticancer
agents. Cell. 74:957–967. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu R, Shtil AA, Tan TH, Roninson IB and
Kong AN: Adriamycin activates c-jun N-terminal kinase in human
leukemia cells: a relevance to apoptosis. Cancer Lett. 107:73–81.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spina A, Sorvillo L, Di Maiolo F, et al:
Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS
cells to doxorubicin via a p53-dependent pathway. J Cell Physiol.
228:198–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gill J, Ahluwalia MK, Geller D and Gorlick
R: New targets and approaches in osteosarcoma. Pharmacol Ther.
137:89–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Radetzki S, Köhne CH, von Haefen C, et al:
The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome
drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast
cancer cell lines. Oncogene. 21:227–238. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tarquini F, Tiribuzi R, Crispoltoni L, et
al: Caspase 3 activation and PARP cleavage in lymphocytes from
newborn babies of diabetic mothers with unbalanced glycaemic
control. Cell Biochem Funct. 32:87–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fong MY, Jin S, Rane M, Singh RK, Gupta R
and Kakar SS: Withaferin A synergizes the therapeutic effect of
doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS
One. 7:e422652012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Jin X, Zhang Z, Xing Y and Kong X:
Inhibition of autophagy enhances apoptosis induced by the
PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Cell Biochem Funct. 31:427–433. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kabeya Y, Mizushima N, Ueno T, et al: LC3,
a mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhong JT, Xu Y, Yi HW, et al: The BH3
mimetic S1 induces autophagy through ER stress and disruption of
Bcl-2/Beclin 1 interaction in human glioma U251 cells. Cancer Lett.
323:180–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang Z, Shi G, Jin J, et al: Dual
PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular
carcinoma cell lines is enhanced by inhibitors of autophagy. Int J
Mol Med. 31:1449–1456. 2013.PubMed/NCBI
|
|
28
|
Fimia GM and Piacentini M: Regulation of
autophagy in mammals and its interplay with apoptosis. Cell Mol
Life Sci. 67:1581–1588. 2010. View Article : Google Scholar : PubMed/NCBI
|
